74 results
8-K
EX-99.1
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
of property and equipment, stock-based compensation and lease expense, partially offset by a net loss of $6.0 million and $0.2 million used for purchase … to a decrease in costs from the Company’s wholly owned subsidiary Cortigent and drug implant development costs, partially offset by increased payroll
DEFA14A
VANI
Vivani Medical Inc
29 Apr 24
Additional proxy soliciting materials
4:32pm
materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
8-K
EX-99.1
dgtcth4d3vf7uw4k9
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
424B5
11vojwp1bgd5v c6
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
npq8wb4cvq jnp8
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.2
emyghoyj mack01
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
kif49uj39arj
1 May 23
Revised proxy
4:49pm
DEFA14A
m1zm7kviz bu
28 Apr 23
Additional proxy soliciting materials
11:29am
8-K
EX-10.1
u99vd
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm